Guidelines for development of diagnostic markers in bladder cancer
✍ Scribed by Peter J. Goebell; Susan L. Groshen; Bernd J. Schmitz-Dräger
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 258 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The term cancerchemoprevention refers to the prevention or prolongation of carcinogenesis by intervention with drugs prior to the malignant (i.e., invasive) stage. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch of the National Cancer Institute. Neoplast
Bladder cancer i s the result of a clonal expansion of cancer cells in which multiple genetic alterations have accumulated. Point mutations of the p53 gene are frequently observed in bladder cancer. Loss of a retinoblastoma (Rb) allele is also common in bladder cancer. Recent data have shown frequen